Cluster Analysis in Phenotyping Patients with Severe Bronchial Asthma
Open Access
- 25 September 2025
- journal article
- Published by Synapse, LLC in The Russian Archives of Internal Medicine
- Vol. 15 (5) , 358-366
Abstract
One in 10 patients with asthma suffers from severe asthma, which is characterized by the presence of several clinical phenotypes. The aim of the study is to identify the clinical phenotypes of patients with difficult-to-control and severe asthma based on cluster analysis. Materials and Methods: A cross-sectional study was conducted, including 200 patients with difficult-to-control asthma. Inclusion criteria: severe and difficult-to-control asthma, all patients received treatment according to the 4th-5th step of the provided guidelines (GINA); age over 18 years. Exclusion criteria: the presence of chronic obstructive pulmonary disease, active infectious diseases, including respiratory infections, oncological diseases, pregnancy. All patients underwent clinical and laboratory tests, and levels of leptin, adiponectin, IL-6, IL-8, IL-4, and TNF-α were measured. To phenotype patients with severe asthma, cluster analysis was performed. Statistical data processing was conducted using SPSS Statistics 20.0 and StatTech v. 4.7.2 (StatTech, Russia). Results: The study included 200 patients with difficult-to-control asthma, with a median age of 53.5 (39.0-59.25) years. As a result of the cluster analysis using the k-means method, 3 clusters were identified. Significant differences were found in BMI, eosinophil count, IgE levels, and leptin (p < 0.001 when comparing the 3 clusters). Differences were also found in the levels of pro-inflammatory cytokines, primarily IL-4 (p=0.003 for the 3 clusters), TNF-α, and IL-8 (p < 0.001 when comparing the 3 clusters). It was established that the development of hypereosinophilia in patients with difficult-to-control asthma may be mediated not only by the IL-4 level (1.326, 95 % CI 1.132-1.554), but also by TNF-α (OR 1.046, 95 % CI 1.022-1.07) and IL-8 (OR 1.054, 95 % CI 1.024-1.085). Conclusion: We identified 3 clusters of patients with difficult-to-control bronchial asthma based on the study of clinical, laboratory, and instrumental data. Each identified cluster is characterized by a specific combination of laboratory markers, which can be taken into account when further treating patients with this asthma phenotype.Keywords
This publication has 20 references indexed in Scilit:
- Cluster analysis of phenotypes, job exposure, and inflammatory patterns in elderly and nonelderly asthma patientsAllergology International, 2024
- Characteristics, phenotypes, mechanisms and management of severe asthmaChinese Medical Journal, 2022
- Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma RegistryThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- The basic immunology of asthmaCell, 2021
- Disease Burden and Long-Term Risk of Persistent Very Poorly Controlled Asthma: TENOR IIThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- Understanding Asthma Phenotypes, Endotypes, and Mechanisms of DiseaseClinical Reviews in Allergy & Immunology, 2018
- Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapiesJournal of Internal Medicine, 2015
- TNF‐alpha is a key mediator in the development of Th2 cell response to inhaled allergens induced by a viral PAMP double‐stranded RNAAllergy, 2012
- Cluster Analysis and Clinical Asthma PhenotypesAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Increased Neutrophil Numbers and IL-8 Levels in Airway Secretions in Acute Severe Asthma: Clinical and Biologic SignificanceAmerican Journal of Respiratory and Critical Care Medicine, 2000